PHARMA

Quarterly rpt on consolidated results for the financial period ended 31/3/2003

PHARMANIAGA BERHAD

Quarterly report for the financial period ended

31/03/2003
Quarter1
Financial Year End31/12/2003
The figureshave not been audited

Attachments

pharma_klse0303.doc
205 KB

SUMMARY OF KEY FINANCIAL INFORMATION
31/03/2003


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
31/03/2003 
31/03/2002 
31/03/2003 
31/03/2002 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
154,525
140,676
154,525
140,676
2Profit/(loss) before tax
17,913
13,492
17,913
13,492
3Profit/(loss)
after tax and minority
interest
11,646
7,342
11,646
7,342
4Net profit/(loss) for
the period
11,646
7,342
11,646
7,342
5Basic earnings/(loss) per share (sen)
11.60
7.30
11.60
7.30
6Dividend per share (sen)
0.00
0.00
0.00
0.00



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR
END
7
Net tangible assets per share (RM)

1.9200
1.8000

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my



Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced20 May 2003  
CategoryFinancial Results
Reference NoCR-030519-31900